Wolverine Blend High Dose (HD) - BPC-157 (15mg) / TB500 (15mg)
The combination is investigated for its complementary roles in tissue repair, angiogenesis, and cellular migration.
The Science
What is the Wolverine Blend?
The Wolverine Blend combines two of the most studied tissue-repair research peptides: BPC-157, a synthetic pentadecapeptide derived from a fragment of human gastric juice protein, and TB-500, a synthetic version of an active region of Thymosin Beta-4.
BPC-157 has been characterized in laboratory studies for cytoprotective effects, accelerated tendon-to-bone healing, gut barrier protection, and modulation of the nitric oxide system. TB-500 acts primarily through actin sequestration, promoting cellular migration, new blood vessel formation, and reduction of fibrotic scarring.
Combined, the two peptides are theorized to act on complementary repair pathways—BPC-157 driving growth factor expression and vascular response, TB-500 enabling progenitor cell mobilization—producing a broader regenerative profile than either compound alone.
Laboratory Observations
Key Observed Effects in Research
Tendon & Ligament Models
Animal studies report accelerated tendon-to-bone healing and improved tensile strength following BPC-157 administration.
Soft-Tissue Repair
TB-500 research demonstrates enhanced wound contraction, re-epithelialization, and reduced inflammatory markers.
Vascular Network Formation
Both peptides independently support angiogenesis; together they show additive vascular endothelial responses in laboratory assays.
Inflammatory Modulation
Reduction of pro-inflammatory cytokines observed across multiple injury models for both compounds.
Gastrointestinal Protection
BPC-157 maintains gut barrier integrity in rodent models exposed to NSAIDs, ethanol, and stress.
Neurological Models
BPC-157 demonstrates neuroprotective effects in traumatic brain injury and stroke models.
Mechanism of Action
Complementary Repair Pathways
BPC-157 and TB-500 act on overlapping but distinct cellular repair systems, providing a layered mechanism of regeneration in laboratory models.
Angiogenic Signaling
BPC-157 upregulates VEGFR-2 expression and modulates the nitric oxide system, supporting the formation of new capillary networks in injured tissue models.
Cellular Migration
TB-500 sequesters G-actin and accelerates the migration of endothelial cells, keratinocytes, and progenitor cells to sites of damage.
Anti-Fibrotic Action
TB-500 modulates inflammatory cytokines and reduces scar tissue formation, while BPC-157 supports orderly collagen deposition in tendon and ligament models.
Cytoprotection
BPC-157 demonstrates protective effects across gastric, hepatic, and neural tissue models, complementing TB-500's systemic regenerative profile.
FAQ
Frequently Asked Questions
Why combine BPC-157 and TB-500?+
Researchers combine the two because their mechanisms are complementary—BPC-157 drives growth factor expression and vascular signaling, while TB-500 enables cell migration and reduces fibrosis. The pairing produces a broader regenerative response in in vitro repair models.
Is there clinical data on the combination?+
No randomized human trials of the blend have been published. Available data comes from animal and cell-culture studies on each peptide individually.
Research-Only Notice
Wolverine Blend High Dose (HD) - BPC-157 (15mg) / TB500 (15mg) is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.